Education: Bachelor degree (Guangxi Medical University, 1977- 1982, major: clinical medicine).
Master (Guangxi Medical University, 1987- 199 1, major: pharmacology)
Doctor (Guangxi Medical University, 2002-2006, major: Oncology)1983 65438+1October to1July 985: Teaching assistant, engaged in the teaching and research of toxicology and medical statistics in the Department of Health of Guangxi Medical University.
1July 1985 to1September 1988: teaching assistant, engaged in teaching and research of pharmacology and clinical pharmacology in the Department of Pharmacology of Guangxi Medical University.
1988 10 turn1993 September: lecturer, engaged in pharmacology and clinical pharmacology teaching and research in the Department of Pharmacology of Guangxi Medical University.
1993 10 turn1999 April: associate professor, engaged in teaching and research of pharmacology and clinical pharmacology in the Department of Pharmacology of Guangxi Medical University.
65438+1April, 1999 to March, 2000: Engaged in tumor pharmacology research at Keke University and Dublin University.
/10 2000 from 2000 to present: Professor, engaged in teaching and research of pharmacology and clinical pharmacology in the Department of Pharmacology of Guangxi Medical University.
Period:1September 1987 to199165438+1October, studying as a postgraduate majoring in pharmacology in Guangxi Medical University.
From September, 2002 to July, 2006, I studied as a doctoral student in oncology major of Guangxi Medical University.
In 2004, he was sent by the country to study in Britain for one year. 1.In 2002, he won the Excellent Teacher Award of Basic Medical College.
2. Won the first prize of teaching achievement in 2000.
3. In 2000, he won the Advanced Teaching Worker Award.
4. Won the 96 School Trade Union Activist Award.
5. Received 9 1 and 2000 Excellent Paper Award from Guangxi Branch of Chinese Pharmacology Society respectively. Analysis and research on the effect of gallic acid on gene expression profile of multidrug-resistant hepatocellular carcinoma cells (Guangxi Science and Technology Department Natural Fund, Guike 0447043, 2004-2007).
2. Study on Xinnaoshenkang, a compound Chinese medicine for the prevention and treatment of cardiovascular and cerebrovascular diseases and renal diseases (Guangxi Science and Technology Department Guikegong Project,No.: Guikegong 0235024, 2003-2005)
3. Study on Reversing Multidrug Resistance of Tumors by Three Catechins (Natural Fund of Guangxi Science and Technology Department,No.: Guikezi 007 1, 2000-2003, completed)
4. Study on the Protective Effect of Catechins on Renal Ischemia-Reperfusion Injury (Project of Guangxi Education Department, 200 1-2003)
Participate in the following topics: drug screening and animal model establishment of nasopharyngeal carcinoma (key project of Guangxi Science and Technology Department, 2003-2006) 1. Effect of free radical scavengers on histamine release from mast cells induced by NaF (National Natural Foundation of China, 9 1-93, main participant).
2. Study on antioxidant damage of total saponins from stems and leaves of Panax notoginseng in Guangxi (Natural Fund of Guangxi Science and Technology Department, 92-93, main participant)
3. Extraction and gene cloning of fibrinolytic enzyme from cobra venom (subject of Guangxi Education Department, 1998-2000, participant)
4. Study on the development of epigallocatechin gallate by using tea extract to prevent and treat cancer (Guangxi Science and Technology Department, Guangxi Branch, 98200 1 year, responsible for some sub-topics of pharmacology)
4. Study on fatigue of transition training of Xinkangtai Nutrition Baokang (Guangxi Science and Technology Department Guike Attack 200 1-2003, participants) 1. Study on antiarrhythmic effects of panax notoginseng saponins and tea polyphenols on quinabine-induced arrhythmia in rats. Journal of Guangxi Medical University, 93; Supplement: 33.
2. The effect of vitamin C on histamine release from rat mast cells induced by sodium fluoride and compound 48/80. China Journal of Pharmacology and Toxicology, 97; 1 1(3):2 18.
3. Liang Gang, Xu, et al. Role of interleukin -2 receptor expression and lysosome content in activated lymphocyte killing. Tumor, (interleukin -2 album), 97; 17(5 supplements): 333.
4. Liang Gang and Huang Zhiming. Antioxidant effects of tea polyphenols and three catechins. Journal of Guangxi Medical University, 98; 15( 1):7.
5. Liang Gang, Huang Zhiming, etc. Experimental study on anti-tumor effect of epigallocatechin gallate (EGCG). Journal of Guangxi Medical University, 2000; 17(2): 176.
Huang Zhiming, Liang Gang, etc. Effect of catechin on arrhythmia. Guangxi Traditional Chinese Medicine, 2000; 23(2):5 1.
7. Liang Gang, Fu, etc. Experimental study on anti-mutation of EGCG. Guangxi Preventive Medicine, 2000; 6(4):20 1.
8. Liang Gang, Huang Ju 'en, et al. Effect of basic fibroblast growth factor on renal ischemia-reperfusion injury in rats. Journal of Guangxi Medical University, 2002; 19(4):465.
9. Huang Zhiming, Liang Gang, et al. Effect of EGCG on renal cell apoptosis in rats with renal ischemia-reperfusion injury. Journal of Guangxi Medical University, 2002; 19(4):476.
10. Liang Gang, Huang Zhiming, et al. Protective effect of EGCG on renal ischemia-reperfusion injury in rats. Bulletin of China Pharmacology, 2003; 19( 1):97.
1 1. Zhang Su, Liang Gang. Research progress of tumor multidrug resistance and its reversal agents. Bulletin of China Pharmacology, 2002; 18(6):6 15-6 17.
12. Zhang Su, Liang Gang. Research progress of natural drugs in reversing multidrug resistance of tumors. China medical abstracts. Oncology. 2002； 16(3):262-263
13. Zhang Su, Liang Gang, et al. Extraction of tea polyphenols from green tea in Guangxi and separation of monomer components. Journal of Guangxi Medical University. 2003; 20(6):77 1-772.
14. Liang Gang, Zhang Su, etc. Reversal of multidrug resistance of human hepatocellular carcinoma cell BEL-7404/Adr by two catechins in vitro, tumor. 2004; 23(4):40 1-405.
15. Liang Gang, Zhang Su, et al. Study on cytotoxicity sensitization of ECG and EGCG on two drug-resistant tumor cells and their structure-activity relationship. Chinese journal of natural medicines magazine. 2004； 2(2): 1 19- 122.
16. Zhang Su, Liang Gang, et al. Effect of catechin on apoptosis of drug-resistant human oral epidermoid cancer cell KV200. Bulletin of Pharmacology of China. 2004; 20( 1): 188- 19 1.
17. Be concise, Liang Gang. Research progress on multi-target effect of natural antioxidants in preventing and treating cardiovascular and cerebrovascular diseases. Huaxia Medicine, 2004; 17( 1): 109- 1 12.
18. Huang Zhiming, Liang Gang, Jane, et al. Protective effect of Xinnaoshenkang on renal ischemia-reperfusion injury in rats. Journal of Guangxi Medical University, 200421(4): 515-516.
19. Protective effect of compound Xinnaoshenkang on focal cerebral ischemia-reperfusion injury. Chinese patent medicine, 2006; 28( 1): 135- 136.
20. Liang Gang, Jian Jie, et al. Intervention effect and mechanism of Xinnaoshenkang on cerebral ischemia. Bulletin of China Pharmacology, 2005; 2 1(8):959-96 1.
2 1. Concise, Li, Liang Gang. Protective effect of Xinnaoshenkang on renal ischemia-reperfusion injury model rats. China Pharmacy, 2006; 17(4):260-262
22. Lin Xiaozhen, Liang Gang, Li Li, etc. Experimental study on EGCG reversing multidrug resistance of human hepatocellular carcinoma drug-resistant cell lines in vivo. Journal of Guangxi Medical University, 2006; 23( 1):8- 1 1.
23. Lin Xiaozhen, Liang Gang, Li Li, etc. Study on cytotoxicity sensitization and antitumor effect of EGCG on two kinds of drug-resistant tumor cells. Pharmacology and Clinical of Traditional Chinese Medicine, 2006,22 (1): 30-33.
24. Lin Xiaozhen, Liang Gang, Tang Anzhou, et al. Effect of EGCG on apoptosis of drug-resistant human oral epidermoid cancer cells in nude mice. Journal of Guangxi Medical University, 2006, to be published.
25. Liang Gang, Lin Xiaozhen, Tang Anzhou, etc. Experimental study on EGCG reversing drug resistance of human drug-resistant oral epidermoid cancer cell line. Cancer Prevention and Treatment Research, 2006, forthcoming.